Latest News Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs go »
Trillium Therapeutics Inc. (TTI) is a private research and development
company. Our goal is to develop therapies that restore balance to the
immune system in conditions associated with abnormal and harmful immune
responses.